Shamoto, Hiroshi http://orcid.org/0000-0002-5431-9581
Koyama, Tamami
Momosaki, Ryo
Maeda, Keisuke
Wakabayashi, Hidetaka
Article History
Received: 15 May 2019
Accepted: 27 January 2020
First Online: 31 January 2020
Ethics approval and consent to participate
: The trial was approved by the Ethics Committee of Minamisoma Municipal General Hospital (the previous place of work of the corresponding author [2–54-6 Takami-chou, Haramachi ward, Minamisoma City, Fukushima, Japan 975–0033. Tel: + 81–244–22-3181, Fax: + 81–244–22-8853]) on October 13, 2016 (Ethics Committee Authorization Number: 28–11) and conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. All participants provided written informed consent. The study was registered in the University Hospital Medical Information Network Clinical Trial Registry (UMIN000025172). This clinical trial followed the CONSORT statement on randomized trials of non-pharmacological treatment.
: Not applicable.
: The Department of Disaster and Comprehensive Medicine, Fukushima Medical University is an endowment department (HS works as a lecturer) that was established from a source other than the university itself (Kowa Yakuhin [the present Alfresa Holdings Corporation], Toshiba Corporation, The Toho Bank, Ltd., Fukushima-Minpo Co., Ltd., Fukushima-Minpo Education Welfare Agency, Nagao Clinic, Johnson & Johnson, Kyowa Hakko Kirin Co., Ltd., and Yasuda Urology Clinic).HW reports grants from the Ministry of Education, Science, Culture, Sports, Science, and Technology of Japan, outside the submitted work.TK, RM, and KM have nothing to disclose.